Annual revenue:
$491.73M+$93.53M(+23.49%)Summary
- As of today (September 10, 2025), CPRX annual revenue is $491.73 million, with the most recent change of +$93.53 million (+23.49%) on December 31, 2024.
- During the last 3 years, CPRX annual revenue has risen by +$350.90 million (+249.16%).
- CPRX annual revenue is now at all-time high.
Performance
CPRX Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly revenue:
$146.56M+$5.14M(+3.64%)Summary
- As of today (September 10, 2025), CPRX quarterly revenue is $146.56 million, with the most recent change of +$5.14 million (+3.64%) on June 30, 2025.
- Over the past year, CPRX quarterly revenue has increased by +$23.85 million (+19.44%).
- CPRX quarterly revenue is now at all-time high.
Performance
CPRX Quarterly revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM revenue:
$558.50M+$23.85M(+4.46%)Summary
- As of today (September 10, 2025), CPRX TTM revenue is $558.50 million, with the most recent change of +$23.85 million (+4.46%) on June 30, 2025.
- Over the past year, CPRX TTM revenue has increased by +$124.02 million (+28.55%).
- CPRX TTM revenue is now at all-time high.
Performance
CPRX TTM revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
CPRX Revenue Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +23.5% | +19.4% | +28.6% |
| 3 y3 years | +249.2% | +175.9% | +227.6% |
| 5 y5 years | +380.6% | +395.1% | +366.3% |
CPRX Revenue Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +249.2% | at high | +175.9% | at high | +227.6% |
| 5 y | 5-year | at high | +380.6% | at high | +399.9% | at high | +372.6% |
| alltime | all time | at high | >+9999.0% | at high | >+9999.0% | at high | >+9999.0% |
CPRX Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $146.56M(+3.6%) | $558.50M(+4.5%) |
| Mar 2025 | - | $141.42M(-0.3%) | $534.65M(+8.7%) |
| Dec 2024 | $491.73M(+23.5%) | $141.82M(+10.2%) | $491.73M(+6.8%) |
| Sep 2024 | - | $128.69M(+4.9%) | $460.48M(+6.0%) |
| Jun 2024 | - | $122.71M(+24.6%) | $434.48M(+5.6%) |
| Mar 2024 | - | $98.51M(-10.9%) | $411.35M(+3.3%) |
| Dec 2023 | $398.20M(+85.9%) | $110.57M(+7.7%) | $398.20M(+14.3%) |
| Sep 2023 | - | $102.69M(+3.1%) | $348.39M(+15.0%) |
| Jun 2023 | - | $99.58M(+16.7%) | $302.95M(+18.1%) |
| Mar 2023 | - | $85.37M(+40.5%) | $256.48M(+19.7%) |
| Dec 2022 | $214.20M(+52.1%) | $60.76M(+6.1%) | $214.20M(+11.7%) |
| Sep 2022 | - | $57.24M(+7.8%) | $191.75M(+12.5%) |
| Jun 2022 | - | $53.11M(+23.3%) | $170.47M(+10.9%) |
| Mar 2022 | - | $43.09M(+12.5%) | $153.72M(+9.1%) |
| Dec 2021 | $140.83M(+18.3%) | $38.31M(+6.6%) | $140.83M(+5.5%) |
| Sep 2021 | - | $35.95M(-1.1%) | $133.54M(+5.2%) |
| Jun 2021 | - | $36.37M(+20.4%) | $126.90M(+5.6%) |
| Mar 2021 | - | $30.20M(-2.6%) | $120.14M(+0.9%) |
| Dec 2020 | $119.07M(+16.4%) | $31.01M(+5.8%) | $119.07M(+0.8%) |
| Sep 2020 | - | $29.32M(-1.0%) | $118.18M(-1.3%) |
| Jun 2020 | - | $29.60M(+1.6%) | $119.76M(+0.6%) |
| Mar 2020 | - | $29.14M(-3.3%) | $118.99M(+16.3%) |
| Dec 2019 | $102.31M(>+9900.0%) | $30.12M(-2.5%) | $102.31M(+40.8%) |
| Sep 2019 | - | $30.90M(+7.1%) | $72.68M(+73.9%) |
| Jun 2019 | - | $28.84M(+131.7%) | $41.79M(+222.7%) |
| Mar 2019 | - | $12.45M(+2389.7%) | $12.95M(+2489.7%) |
| Dec 2018 | $500.00K(>+9900.0%) | $500.00K(>+9900.0%) | $500.00K(>+9900.0%) |
| Sep 2018 | - | $0.00(0.0%) | $0.00(0.0%) |
| Jun 2018 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2018 | - | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2017 | $0.00(0.0%) | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2017 | - | $0.00(0.0%) | $0.00(0.0%) |
| Jun 2017 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2017 | - | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2016 | $0.00(0.0%) | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2016 | - | $0.00(0.0%) | $0.00(0.0%) |
| Jun 2016 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2016 | - | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2015 | $0.00 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2015 | - | $0.00(0.0%) | $0.00(0.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2015 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2015 | - | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2014 | $0.00(0.0%) | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2014 | - | $0.00(0.0%) | $0.00(0.0%) |
| Jun 2014 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2014 | - | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2013 | $0.00(0.0%) | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2013 | - | $0.00(0.0%) | $0.00(0.0%) |
| Jun 2013 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2013 | - | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2012 | $0.00(0.0%) | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2012 | - | $0.00(0.0%) | $0.00(0.0%) |
| Jun 2012 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2012 | - | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2011 | $0.00(0.0%) | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2011 | - | $0.00(0.0%) | $0.00(0.0%) |
| Jun 2011 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2011 | - | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2010 | $0.00(0.0%) | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2010 | - | $0.00(0.0%) | $0.00(0.0%) |
| Jun 2010 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2010 | - | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2009 | $0.00(0.0%) | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2009 | - | $0.00(0.0%) | $0.00(0.0%) |
| Jun 2009 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2009 | - | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2008 | $0.00(0.0%) | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2008 | - | $0.00(0.0%) | $0.00(0.0%) |
| Jun 2008 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2008 | - | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2007 | $0.00(0.0%) | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2007 | - | $0.00(0.0%) | $0.00(0.0%) |
| Jun 2007 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2007 | - | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2006 | $0.00(0.0%) | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2006 | - | $0.00 | $0.00 |
| Dec 2005 | $0.00(0.0%) | - | - |
| Dec 2004 | $0.00(0.0%) | - | - |
| Dec 2003 | $0.00(0.0%) | - | - |
| Dec 2002 | $0.00 | - | - |
FAQ
- What is Catalyst Pharmaceuticals, Inc. annual revenue?
- What is the all time high annual revenue for Catalyst Pharmaceuticals, Inc.?
- What is Catalyst Pharmaceuticals, Inc. annual revenue year-on-year change?
- What is Catalyst Pharmaceuticals, Inc. quarterly revenue?
- What is the all time high quarterly revenue for Catalyst Pharmaceuticals, Inc.?
- What is Catalyst Pharmaceuticals, Inc. quarterly revenue year-on-year change?
- What is Catalyst Pharmaceuticals, Inc. TTM revenue?
- What is the all time high TTM revenue for Catalyst Pharmaceuticals, Inc.?
- What is Catalyst Pharmaceuticals, Inc. TTM revenue year-on-year change?
What is Catalyst Pharmaceuticals, Inc. annual revenue?
The current annual revenue of CPRX is $491.73M
What is the all time high annual revenue for Catalyst Pharmaceuticals, Inc.?
Catalyst Pharmaceuticals, Inc. all-time high annual revenue is $491.73M
What is Catalyst Pharmaceuticals, Inc. annual revenue year-on-year change?
Over the past year, CPRX annual revenue has changed by +$93.53M (+23.49%)
What is Catalyst Pharmaceuticals, Inc. quarterly revenue?
The current quarterly revenue of CPRX is $146.56M
What is the all time high quarterly revenue for Catalyst Pharmaceuticals, Inc.?
Catalyst Pharmaceuticals, Inc. all-time high quarterly revenue is $146.56M
What is Catalyst Pharmaceuticals, Inc. quarterly revenue year-on-year change?
Over the past year, CPRX quarterly revenue has changed by +$23.85M (+19.44%)
What is Catalyst Pharmaceuticals, Inc. TTM revenue?
The current TTM revenue of CPRX is $558.50M
What is the all time high TTM revenue for Catalyst Pharmaceuticals, Inc.?
Catalyst Pharmaceuticals, Inc. all-time high TTM revenue is $558.50M
What is Catalyst Pharmaceuticals, Inc. TTM revenue year-on-year change?
Over the past year, CPRX TTM revenue has changed by +$124.02M (+28.55%)